Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence

Gynecologic Oncology
Christina WefersStanleyson V Hato

Abstract

Ovarian cancer is a devastating disease with a high relapse rate. Due to a mostly asymptomatic early stage and lack of early diagnostic tools, the disease is usually diagnosed in a late stage. Surgery and chemotherapy with taxanes and platinum compounds are very effective in reducing tumor burden. However, relapses occur frequently and there is a lack of credible second-line options. Therefore, new treatment modalities are eagerly awaited. The presence and influx of immune cells in the ovarian cancer tumor microenvironment are correlated with survival. High numbers of infiltrating T cells correlate with improved progression free and overall survival, while the presence of regulatory T cells and expression of T cell inhibitory molecules is correlated with a poor prognosis. These data indicate that immunotherapy, especially cell-based immunotherapy could be a promising novel addition to the treatment of ovarian cancer. Here, we review the available data on the immune contexture surrounding ovarian cancer and discuss novel strategies and targets for immunotherapy in ovarian cancer. In the end the addition of immunotherapy to existing therapeutic options could lead to a great improvement in the outcome of ovarian cancer, especially...Continue Reading

References

Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Apr 22, 2003·Nature Medicine·Tyler J CurielWeiping Zou
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A D SantinS Pecorelli
Aug 18, 2004·Cancer Research·Tyler J CurielWeiping Zou
Sep 11, 2004·Journal of Clinical Immunology·Mary L DisisKeith L Knutson
Aug 30, 2005·Gynecologic Oncology·Manish S PatankarGary F Clark
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Feb 8, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maurie Markman, Joan L Walker
Apr 12, 2006·The Journal of Experimental Medicine·Ilona KryczekWeiping Zou
Apr 15, 2006·American Journal of Clinical Pathology·Hiep Phuc DongBjörn Risberg
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael H KershawPatrick Hwu
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Junzo HamanishiShingo Fujii
Jan 1, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Richard J Jones, William Matsui
Apr 9, 2008·European Journal of Immunology·Maria-Grazia Roncarolo, Silvia Gregori
Apr 24, 2008·Journal of Translational Medicine·Vaios KaranikasAnastasios E Germenis
May 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Catherine S M DiefenbachJakob Dupont
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard W TothillDavid D L Bowtell
Oct 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yoshihiro MiyaharaRong-Fu Wang
Jul 22, 2009·International Journal of Cancer. Journal International Du Cancer·Ninke LeffersHans W Nijman
Sep 3, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Prema P PeethambaramJohn W Park
Sep 29, 2009·Journal of Cellular and Molecular Medicine·Chiara NapoletanoMarianna Nuti
Feb 11, 2010·Current Opinion in Immunology·Alberto Mantovani, Antonio Sica
Mar 18, 2010·The Journal of Clinical Investigation·Rupal RamakrishnanDmitry I Gabrilovich
Mar 26, 2010·Nature Reviews. Immunology·Weiping Zou, Nicholas P Restifo
Jun 24, 2011·Cancer Research·Sana Intidhar Labidi-GalyNathalie Bendriss-Vermare
Jul 19, 2011·The Journal of Clinical Investigation·W Joost LesterhuisI Jolanda M de Vries
Nov 2, 2011·Gynecologic Oncology·Wei-Ting HwangGeorge Coukos
Nov 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianDrew M Pardoll
Mar 23, 2012·Nature Reviews. Immunology·Eric VivierLaurent Brossay
Mar 23, 2012·Nature Reviews. Immunology·Nicholas P RestifoSteven A Rosenberg
Mar 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kunle OdunsiElke Jäger
May 23, 2012·Clinical & Developmental Immunology·Esdy N RozaliW Joost Lesterhuis
Jun 22, 2012·Oncoimmunology·Stanleyson V HatoW Joost Lesterhuis

❮ Previous
Next ❯

Citations

May 18, 2016·Journal of Ovarian Research·Gloria MitticaGiorgio Valabrega
May 14, 2016·Gynecologic Oncology·Taylor B TurnerRebecca C Arend
May 13, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Chih-Hsing ChouMin-Chuan Huang
Dec 18, 2018·Frontiers in Oncology·Thijs RoelofsenAnne M van Altena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

© 2022 Meta ULC. All rights reserved